Alok Khorana: Six Years of Growth and Transformation at National Blood Clot Allianceat
Alok Khorana, Vice Chair of the Taussig Cancer Institute at Cleveland Clinic, shared a post on LinkedIn:
“It’s been a dynamic six years of growth and transformation as I reach the end of my second and final term as Chair of the Medical and Scientific Advisory Board of National Blood Clot Alliance. From creating the Council for Emerging Researchers in Thrombosis (CERT) to effective public policy advances at state and federal levels such as the passage of the Emily Adkins Act in Florida, I couldn’t have asked for a better partner than Leslie Lake. She is an inspirational leader who has changed the boundaries of what’s possible in this patient-led organization.
I’m excited to hand off leadership to incoming Chair Jeffrey Zwicker who I’m absolutely confident will lead the Board to newer and greater heights.
Finally, I’m absolutely delighted to remain involved with MASAB and NBCA as Chair Emeritus. Much has been done to alleviate the public health and individual burden of thromboembolism but much remains to be done.”
Stay updated with Hemostasis Today.
-
Mar 30, 2026, 17:02Phil Choi: 50 Times a Life Saver
-
Mar 30, 2026, 15:49Archil Jaliashvili: How Patients and Care Partners Navigate Chronic Illness and Transplant Medicine
-
Mar 30, 2026, 15:47Omar Adwan: Clinical and Laboratory Features of Megaloblastic Anemia
-
Mar 30, 2026, 15:38Gopal Patidar: Updates on Techniques and Applications in Therapeutic Apheresis with ISBT
-
Mar 30, 2026, 15:34Heghine Khachatryan: Advancing Health Equity in Hemophilia Care – From Resolution to Real Impact
-
Mar 30, 2026, 15:31Reza Shojaei: The Presence of Microplastics in Blood Signals a New Era for Transfusion Medicine
-
Mar 30, 2026, 15:26Akshat Jain: Turning Real-World Data into Smarter Prophylaxis for Hemophilia A
-
Mar 30, 2026, 15:24Chepsy C Philip: Learning from a Legend in Transplant Medicine
-
Mar 30, 2026, 15:23Jim HoffmanÖ‰ Targeting NETosis to Help Autoimmune and Post-Infection Syndromes